eHealth, Inc. (EHTH)

Score 3 (Mixed): EHTH is very inexpensive on operating multiples (EV/Sales ~0.20; EV/EBITDA ~1.50) and leverage looks manageable (net debt/EBITDA ~0.93) with reported liquidity around ~$101m as of 2026-06-30. However, recent filings show sharp YoY declines in revenue/approved members in Q2 2026, free cash flow remains slightly negative (FCF yield ~-3.6%), and the business carries meaningful regulatory/covenant complexity. This is more of a high-upside value/turnaround setup than a stable, low-risk compounder today.

No forward-dated corporate catalyst sits inside the 1–30 trading day horizon — official PR flow is limited to two non-material survey releases and the August 4 Q2 print is fully digested — while third-party coverage is sparse and essentially flat (two on-topic scored items at +0.1 and 0.0) and the numeric sentiment delta is indeterminate for lack of a scored baseline. An active False Claims Act qui tam with U.S. government partial intervention and a March 2026 motion-to-dismiss denial carries a moderate red-flag cap, and with no rewarded bullish catalyst to offset it the setup is weak/absent.

Broken downtrend: price $0.8889 sits below the SMA20 ($1.05), SMA50 ($1.25), SMA200 ($2.06), EMA9 ($0.94) and EMA21 ($1.04) — the full moving-average stack is bearish and price is pinned near the 52-week low ($0.87). ADX14 at 44.1 with price under every key average is a strong DOWN trend, not a base; RSI14 27.1 and Williams %R -94.8 are oversold but in this regime oversold persists. MACD (-0.11/-0.10) is below zero and only flattening. There is no tradable bullish setup, and hard blocks preclude any entry regardless: qualitativeScore 2 (below the required floor of 3, no shadow eligibility) and liquidity far under the floor (20-day average dollar volume ~$313K vs the $5M floor; recent 3-session ~$226K vs the $1.5M recent-liquidity floor).